[Directed molecular evolution of antibodies].

Area of Science:

• Immunology and Molecular Biology
• Biotechnology and Genetic Engineering

Context:

• Antibodies are crucial for immune response, with specificity arising from genetic processes.
• Monoclonal antibody production, pioneered by Kohler and Milstein, has expanded their use in medicine.
• Engineered antibodies (chimeric, humanized) are vital for immunotherapy, with around twenty approved for human use.

Purpose:

• To explore the role of in vitro molecular evolution in antibody engineering.
• To demonstrate the potential of improving antibody specificity, affinity, and stability.
• To illustrate these advancements using an anti-progesterone antibody example.

Summary:

• Antibodies, despite a fixed gene set, achieve diverse recognition through genetic recombination and mutation.
• In vitro molecular evolution offers advanced methods to engineer antibody properties like affinity and specificity.
• This technique enhances antibody utility for research, diagnostics, and therapeutic applications.

Impact:

• Advances in antibody engineering significantly broaden their applications in clinical settings.
• In vitro molecular evolution provides powerful tools for tailoring antibody characteristics for specific needs.
• Improved antibody specificity and affinity through engineering enhance diagnostic and therapeutic outcomes.